FDA volatility Archives - The Herald Today

Rare Disease Drugs Drive Pharma Growth Despite Challenges

Rare Disease Drug Sales to Exceed $400 Billion by 2032 The rare disease drug market is on track for remarkable...

By Web Desk | March 14, 2026 | Category: Business, Health, World

OPINION

Patent Expirations Set Biopharma on a Tough Path for 2026 The biopharma industry is entering 2026 with uncertainty, as patent...

Published about 9 hours ago

Pharmacists at the Heart of Multiple Sclerosis Care Multiple sclerosis (MS) is a chronic, unpredictable disease that requires a coordinated...

Published about 2 days ago

Genomics and Birth Defects: A New Era of Discovery Public health genomics is reshaping how we understand birth defects, offering...

Published about 3 days ago